Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?

被引：7

作者：

Bilous, R. W. ^{[1
]}

机构：

[1] James Cook Univ Hosp, Middlesbrough, Cleveland, England

来源：

DIABETIC MEDICINE | 2007年 / 24卷 / 09期

关键词：

D O I：

10.1111/j.1464-5491.2007.02259.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：931 / 933

页数：3

共 21 条

[1] [Anonymous], 2007, LANCET, V369, P1834, DOI [10.1016/S0140-6736(07)60787-9, 10.1056/NEJMoao66224]
[2] Misleading meta-analysis: a need to look beyond the headlines
Chaturvedi, N.
Bilous, R.
Hardy, R.
Remuzzi, G.
Ruggenenti, P.
Viberti, G. C.
[J]. DIABETIC MEDICINE, 2007, 24 (06) : 587 - 591
[3] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
Dormandy, JA
Charbonnel, B
Eckland, DJA
Erdmann, E
Massi-Benedetti, M
Kmoules, IK
Skene, AM
Tan, MH
Lefébvre, PJ
Murray, GD
Standl, E
Wilcox, RG
Wlhelmsen, L
Betteridge, J
Birkeland, K
Golay, A
Heine, RJ
Korányi, L
Laakso, M
Mokán, M
Norkus, A
Pirags, V
Podar, T
Scheen, A
Scherbaum, W
Schernthaner, G
Schmitz, O
Skrha, J
Smith, U
Taton, J
[J]. LANCET, 2005, 366 (9493) : 1279 - 1289
[4] Rosiglitazone - Continued uncertainty about safety
Drazen, Jeffrey M.
Morrissey, Stephen
Curfman, Gregory D.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) : 63 - 64
[5] Faster publication isn't always better
Fuster, Valentin
Farkouh, Michael E.
[J]. NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (07): : 345 - 345
[6] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
Gerstein, H. C.
Yusuf, S.
Holman, R. R.
Bosch, J.
Anand, S.
Avezum, A.
Budaj, A.
Chiasson, J.
Conget, I.
Dagenais, G.
Davis, M.
Diaz, R.
Dinccag, N.
Enjalbert, M.
Escalante, A.
Fodor, G.
Hanefeld, M.
Hedner, T.
Jolly, K.
Keltai, M.
Laakso, M.
Lanas, F.
Lonn, E.
McQueen, M.
Mohan, V.
Phillips, A.
Piegas, L.
Pirags, V.
Probstfield, J.
Shaw, J.
Schmid, I.
Teo, K.
Zimmet, P.
Zinman, B.
Gerstein, H. C.
Yusuf, S.
Bosch, J.
Pogue, J.
Sheridan, P.
Dinccag, N.
Hanefeld, M.
Hoogwerf, B.
Laakso, M.
Mohan, V.
Shaw, J.
Zinman, B.
Holman, R. R.
Diaz, R.
Ahuad Guerrero, R.
Albisu, J.
[J]. LANCET, 2006, 368 (9541) : 1096 - 1105
[7] *GLAXOSMITHKLINE, ZM20050018101 GLAXOS
[8] Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis
Home, Philip D.
Pocock, Stuart J.
Beck-Nielsen, Henning
Gomis, Ramon
Hanefeld, Markolf
Jones, Nigel P.
Komajda, Michel
McMurray, John J. V.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) : 28 - 38
[9] *INF CTR, 2007, REP PRESCR DIAB PRIM
[10] Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, Steven E.
Haffner, Steven M.
Heise, Mark A.
Herman, William H.
Holman, Rury R.
Jones, Nigel P.
Kravitz, Barbara G.
Lachin, John M.
O'Neill, M. Colleen
Zinman, Bernard
Viberti, Giancarlo
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) : 2427 - 2443

← 1 2 3 →